ETRAVIRINE
NDC 69315-286, ETRAVIRINE, tablet, from Leading Pharma, LLC.
- Product NDC
- 69315-286
- Status
- Listed
- Labeler
- Leading Pharma, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA215402
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69315-286 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ETRAVIRINE200 mg/1
Pharmacologic classes
Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 2C9 Inhibitors [MoA]; Cytochrome P450 3A Inducers [MoA]; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Non-Nucleoside Analog [EXT]; Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69315-286-06 | 69315028606 | 60 TABLET in 1 BOTTLE (69315-286-06) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/48ffeac8-38e8-4007-903a-dbffce25d679NADAC price for package 69315028606
GET /v1/drugs/nadac/69315028606
Use it
Look up 69315-286 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69315-286 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69315-286. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.